Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Limitations of current therapies
3 evidence topics · 4 sources
Summary
Current care includes low-vision aids, vision rehabilitation, and measures to limit avoidable retinal stress. The National Eye Institute describes no treatment for Stargardt disease, while the 2026 management review identifies supportive care as foundational. The 2018 technology assessment reported limitations in the size, duration, and quality of studies available at that time; it predates the completed DRAGON trial.